Tech support
Shopping Cart
Login
Register
Forgot Password?
Products
Diagnostics
Suppliers
About us
Contact
+31 (0)26 326 4450
Find the product you need
Description
Catalog number
CAS No.
Clone ID
News
Vorige
Volgende
InVivoPlus anti-mouse CD40
Catalog number:
BP0016-2_100mg
Brand:
Bio X Cell
Packing:
100 mg
Other sizes:
Other sizes available
Price:
€ 4062.00
Expected delivery time:
7 days
Quantity:
Spin Up
Spin Down
General
References
Product specifications for - InVivoPlus anti-mouse CD40
Promotion:
Promotion:
The price displayed is only for academic or non-profit organizations. Please
contact our helpdesk
for regular prices.
Overview:
Product group:
Antibodies
Category:
Primary Antibodies
Application:
Other Application
Host:
Rat
Clonality:
Monoclonal
Isotype:
IgG2a
Properties:
Molecular weight:
150 kDa
Datasheet:
Datasheet
Research Use Only
UNSPSC:
12352203
Concentration:
2-10 mg/ml
Scientific information:
Clone ID:
FGK4.5/FGK45
Related products:
Related products:
Recommended Isotype Control(s):
InVivoPlus rat IgG2a isotype control (BP0089)
Recommended Dilution Buffer:
InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information:
Synonyms:
FGK4.5/FGK45; BP0016-2; CD40; p50; TNFRSF5; CDW40; Bp50; tumor necrosis factor receptor superfamily, member 5; tumor necrosis factor receptor superfamily member 5; nerve growth factor receptor-related B-lymphocyte activation molecule; CD40L receptor; CD40 type II isoform; CD40 antigen (TNF receptor superfamily member 5); B-cell surface antigen CD40; B cell-associated molecule; B cell surface antigen CD40; CD40 molecule, TNF receptor superfamily member 5; BioXCell
Xu H, Chaudhri VK, Wu Z, et al. Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8. Nat Immunol. 2015;16(12):1274-81.
Read more
Bartkowiak T, Singh S, Yang G, et al. Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine. Proc Natl Acad Sci USA. 2015;112(38):E5290-9.
Read more
Conde P, Rodriguez M, Van der touw W, et al. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance. Immunity. 2015;42(6):1143-58.
Read more
Carmi Y, Spitzer MH, Linde IL, et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 2015;521(7550):99-104.
Read more
Erickson JJ, Rogers MC, Hastings AK, Tollefson SJ, Williams JV. Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection. J Immunol. 2014;193(10):5108-17.
Read more
Muppidi JR, Schmitz R, Green JA, et al. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma. Nature. 2014;516(7530):254-8.
Read more
Sandin LC, Orlova A, Gustafsson E, et al. Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer. Cancer Immunol Res. 2014;2(1):80-90.
Read more
Rabenstein H, Behrendt AC, Ellwart JW, et al. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells. J Immunol. 2014;192(8):3507-17.
Read more
Hailemichael Y, Dai Z, Jaffarzad N, et al. Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion. Nat Med. 2013;19(4):465-72.
Read more
Locatelli G, Wörtge S, Buch T, et al. Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat Neurosci. 2012;15(4):543-50.
Read more
See All